WO2002008134A1 - Borosilicatglas hoher chemischer beständigkeit und dessen verwendungen - Google Patents
Borosilicatglas hoher chemischer beständigkeit und dessen verwendungen Download PDFInfo
- Publication number
- WO2002008134A1 WO2002008134A1 PCT/EP2001/008285 EP0108285W WO0208134A1 WO 2002008134 A1 WO2002008134 A1 WO 2002008134A1 EP 0108285 W EP0108285 W EP 0108285W WO 0208134 A1 WO0208134 A1 WO 0208134A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glass
- borosilicate glass
- glasses
- weight
- glass according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C3/00—Glass compositions
- C03C3/04—Glass compositions containing silica
- C03C3/076—Glass compositions containing silica with 40% to 90% silica, by weight
- C03C3/095—Glass compositions containing silica with 40% to 90% silica, by weight containing rare earths
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C3/00—Glass compositions
- C03C3/04—Glass compositions containing silica
- C03C3/076—Glass compositions containing silica with 40% to 90% silica, by weight
- C03C3/089—Glass compositions containing silica with 40% to 90% silica, by weight containing boron
- C03C3/091—Glass compositions containing silica with 40% to 90% silica, by weight containing boron containing aluminium
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C3/00—Glass compositions
- C03C3/04—Glass compositions containing silica
- C03C3/076—Glass compositions containing silica with 40% to 90% silica, by weight
- C03C3/089—Glass compositions containing silica with 40% to 90% silica, by weight containing boron
- C03C3/091—Glass compositions containing silica with 40% to 90% silica, by weight containing boron containing aluminium
- C03C3/093—Glass compositions containing silica with 40% to 90% silica, by weight containing boron containing aluminium containing zinc or zirconium
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C4/00—Compositions for glass with special properties
- C03C4/20—Compositions for glass with special properties for chemical resistant glass
Definitions
- the invention relates to a borosilicate glass of high chemical resistance and its uses.
- An essential parameter for characterizing the processability of a glass is the processing temperature V A , at which the viscosity of the glass is 10 4 dPas. It should be low, since even slight V A reductions lead to a significant reduction in manufacturing costs, since the melting temperatures can be reduced. In addition, the lowest possible V A is also advantageous in the production of the glass-metal fusion, since overheating of the parts to be melted can then be avoided because melting can take place either at a lower temperature or in a shorter time. Finally, when using glasses with a lower V A , it can be avoided that evaporation and recondensation of glass components lead to a malfunction of the fusion and, in the worst case, to leaky fusion.
- the processing interval of a glass ie the temperature difference from the processing temperature V A to the softening temperature E Wl of the temperature at which the viscosity of the Glases 10 7.6 dPas is essential.
- the temperature range in which a glass can be processed is also referred to as the "length" of the glass.
- Glasses which have a very high chemical resistance to acidic and alkaline media and in particular a very high hydroytic resistance are also required for use as pharmaceutical primary packaging such as ampoules or vials.
- a low coefficient of thermal expansion is also advantageous because it ensures good temperature resistance.
- the physicochemical behavior of the glass in its further processing is also important, since it influences the properties of the end product and its possible uses.
- Patent specification DE 42 30 607 C 1 presents chemically highly resistant borosilicate glasses that can be fused with tungsten. They have expansion coefficients ⁇ 2 o3oo of at most 4.5 x 10 "6 / K and, as shown in the examples, processing temperatures> 1210 ° C.
- the borosilicate glasses described in published patent application DE 37 22 130 A1 also have a low elongation of at most 5.0 x 10 "6 / K.
- the glasses of the patent specification DE 44 30 710 C1 have a relatively high SiO 2 content, namely> 75% by weight and> 83% by weight SiO 2 + B 2 O 3 in connection with a nem weight ratio SiO 2 / B 2 O 3 > 8, and little AI 2 O 3 , which makes them chemically highly resistant, but leads to disadvantageously high processing temperatures.
- the glasses of DE 198 42 942 A1 and DE 195 36 708 C1 have a very high chemical resistance belonging to hydrolytic, acid and alkali class 1. However, due to their Zr0 2 proportions, the disadvantages mentioned also apply to them.
- the glass according to the invention has an SiO 2 content of 70 to 77% by weight, preferably 70.5 to 76.5% by weight of SiO 2 . Higher proportions would raise the processing temperature too much and lower the coefficient of thermal expansion too much. If the SiO 2 content were reduced further, the acid resistance in particular would deteriorate. An SiO 2 content of ⁇ 75% by weight is particularly preferred.
- the glass contains 6 to ⁇ 11.5% by weight, preferably 6.5 - ⁇ 11.5% by weight, particularly preferably at most 11% by weight of B 2 O 3 .
- B 2 O 3 leads to a lowering of the processing temperature and the melting temperature with simultaneous improvement hydrolytic resistance.
- B 2 O 3 binds the alkali ions present in the glass more firmly into the glass structure. While the melting temperature would not be lowered far enough and the tendency to crystallize would increase at lower contents, the acid resistance would deteriorate at higher contents.
- the glass according to the invention contains between 4 and 8.5% by weight, preferably up to 8% by weight, of Al 2 O 3 . Similar to B 2 O 3, this component binds the alkali ions more firmly into the glass structure and has a positive effect on the resistance to crystallization. At lower contents, the tendency to crystallize would increase accordingly and, particularly at high B 2 O 3 contents, there would be an increased evaporation of alkali. Too high levels would disadvantageously result in an increase in the processing and melting temperature.
- the glasses contain 4-9.5% by weight, preferably 4.5-9% by weight Na 2 O. They can contain up to 5% by weight K 2 O and up to 2% by weight, preferably up to contain 1.5% by weight of Li 2 O.
- the sum of the alkali oxides is between 5 and 11% by weight, preferably between 5.5 and 10.5% by weight, particularly preferably between 7.5 and ⁇ 10.5% by weight.
- the alkali oxides lower the processing temperature of the glasses and are largely responsible for the adjustment of the thermal expansion. Above the respective upper limits, the glasses would have too high coefficients of thermal expansion. In addition, too high a proportion of the components would impair the hydrolytic resistance. It is also recommended for reasons of cost to limit the use of K 2 O and Li 2 O to the specified maximum levels.
- the glass can contain the divalent oxides MgO with 0-2% by weight, preferably 0-1% by weight, and CaO with 0-2.5% by weight, preferably 0-2% by weight 0 - ⁇ 2 wt .-%, included.
- the sum of these two components is between 0 and 3% by weight, preferably between 0 and ⁇ 3% by weight.
- the two components vary the "length of the glass", that is to say the temperature range in which the glass can be processed. Due to the different degree of network-changing effect of these components, the viscosity behavior can be adapted to the requirements of the respective production and processing method by exchanging these oxides for one another.
- CaO and MgO lower the processing temperature and are firmly bound in the glass structure. Surprisingly, it has been shown that the restriction to low CaO contents reduces the evaporation of volatile sodium and potassium borate compounds during hot molding. This is of particular importance with Al 2 O 3 contents, while with high Al 2 O 3 contents comparatively high CaO contents are tolerated. CaO improves acid resistance.
- the glass also applies to the ZnO component, which can be up to 1% by weight in the glass.
- the glass can contain up to 1.5% by weight of SrO and up to 1.5% by weight of BaO, which increases the resistance to devitrification. The sum of these two components is between 0 and 2% by weight.
- the glass is preferably free of SrO and BaO. For use as pharmaceutical primary packaging in particular, it is advantageous if the glass is BaO-free.
- the glass can contain coloring components, preferably Fe 2 O 3 , Cr 2 O 3 , CoO, each with up to 1% by weight, the sum of these components also not exceeding 1% by weight.
- the glass can also contain up to 3% by weight of TiO 2 . This component is preferably used when damage to a glass-metal fusion by UV radiation or the release of UV radiation is to be prevented in special fields of application of the glass.
- the glass can contain up to ⁇ 0.5% by weight of ZrO 2 , which results in an improvement in the alkali resistance.
- the ZrO 2 content is limited to this low maximum value, since the processing temperature would increase too much with higher proportions.
- the risk of glass defects increases with high ZrO 2 contents, since particles of the poorly soluble ZrO 2 raw material may remain unmelted and get into the product.
- the glass can contain up to 1% by weight of CeO 2 . In low concentrations CeO 2 acts as a refining agent, in higher concentrations it prevents the glass from becoming discolored by radioactive radiation. Meltings made with such a glass containing Ce0 2 can therefore be checked visually for possible damage such as cracks or corrosion of the lead wire even after radioactive exposure. Even higher Ce0 2 concentrations make the glass more expensive and lead to an undesirable yellow-brown color. For uses in which the ability to avoid discoloration due to radioactive radiation is not essential, a CeO 2 content between 0 and 0.3% by weight is preferred.
- the glass can contain up to 0.5% by weight of F " . This lowers the viscosity of the melt, which accelerates the refining.
- the glass can be refined with customary refining agents such as chlorides, for example NaCl, and / or sulfates, for example Na 2 SO 4 or BaSO 4 , in customary amounts, that is to say depending on The quantity and type of refining agent used can be found in the finished glass in quantities of 0.005 to 1% by weight. If As 2 0 3 , Sb 2 O 3 and BaS0 4 are not used, the glasses are As 2 O 3 -, Sb 2 O 3 - and BaO-free except for inevitable impurities, which is particularly advantageous for their use as pharmaceutical primary packaging.
- customary refining agents such as chlorides, for example NaCl, and / or sulfates, for example Na 2 SO 4 or BaSO 4
- the jars were made as follows: The raw materials were weighed and mixed thoroughly. The glass batch was melted at approx. 1600 ° C and then poured into steel molds.
- Table 1 are the respective composition (in wt .-% on an oxide basis), the thermal expansion coefficient ⁇ 20/3 oo [10 "6 / K], the transformation temperature T g [° C], the softening temperature Ew, the processing temperature V A [° C], which corresponds to the temperature at the viscosity 10 4 dPas, the temperature at the viscosity 10 3 dPas L3 [° C] and the difference L3 - V A [K], the density [g / cm 3 ] and the hydrolytic, acid and alkali resistance of the glasses.
- the chemical resistance was determined as follows:
- the hydrolytic resistance H according to DIN ISO 719.
- the base equivalent of the acid consumption is given in each case as ⁇ g Na 2 O / g glass powder.
- the maximum value for a chemically highly resistant glass of hydrolytic class 1 is 31 ⁇ g Na 2 O / g.
- the alkali resistance L according to DIN ISO 695.
- the weight loss is given in ⁇ g / dm 2 .
- the maximum erosion for a glass of lye class 1 (slightly soluble in lye) is 75 mg / dm 2 .
- the maximum removal for a glass of alkali class 2 (moderately soluble in caustic solution) is 175 mg / dm 2 .
- the glasses according to the invention are extremely suitable for all applications in which chemically highly resistant glasses are required, for. B. for laboratory applications, for chemical plants, for example as pipes.
- the glasses have a thermal expansion coefficient ⁇ 2 o / 3 oo between> 5.0 and 6.0 x 10 "6 / K, in a preferred embodiment of at least> 5.2 x 10 " 6 / K and in a particularly preferred embodiment between> 5.3 and 5.9 x 10 "6 / K, which can be varied, in particular, via the alkali content.
- the glasses are suitable for solder and melt-down glasses and as cladding glasses for glass fibers.
- compositions in% by weight on oxide basis
- nb not determined
- the glasses according to the invention have small temperature differences between L3, the temperature at the viscosity 10 3 dPas, and V A , the temperature at the viscosity 10 4 dPas, namely less than 250 K. This is advantageous for the further processing of thermoformed glass products, since the Alkaline evaporation is reduced. As thermogravimetric studies show, it is not only dependent on the processing temperature V A , but also on the further viscosity curve towards lower viscosities.
- Figure 1 shows the result of a thermogravimetric examination for 2 example glasses according to the invention (A3 and A4).
- the mass loss [%] is plotted against log (viscosity [dPas]).
- the glass samples show a slight loss of mass, which, like mass spectrometric studies or X-ray studies on condensation products from the melting process, can be attributed to the evaporation of alkali borates.
- the figure shows that a small temperature difference L3 - V A is desirable to minimize alkali evaporation.
- Time-dependent spectrometer measurements were carried out on some sample and comparison glasses.
- the spectrometer measurements are carried out on heated rotating cylindrical samples with a diameter of approx. 4 mm with a multi-channel spectrometer Zeiss MMS1. Stimulated by the supply of heat from a gas burner, the alkali ions emerging from the glass emit light of a specific wavelength, for example at approx. 589 nm (Na), 767 nm (K) and 670 nm (Li).
- the respective signals increase continuously with increasing test duration, which is approximately proportional to the energy input and which also means a correspondingly decreasing viscosity of the samples.
- Table 2 shows exemplary spectrometer data for glasses A8 - A12 and V1 - V2. For their compositions, reference is made to Table 1. All the numerical values listed in Table 2 represent mean values over 7 measurements on different samples from the same casting. The intensities of Examples A8, A9 and A11 are given in relation to the intensity values of V1. The intensities of A10 and A12 and V3 were compared to V2. I (Li) of A8 and A9 is not given because the reference value is missing because V1 is Li-free. I (Li) of A8 and A9 is considered in I (total) of A8 and A9.
- This formula is usually used for the calculation of indicators of surface resistance of ampoules and vials according to ISO 4802-2.
- the alkalis are determined by flame photometry and the result is given as the equivalent Na 2 0 (ppm).
- the factors therefore correspond to the ratios of the molar weights Na 2 O / K 2 O or Na 2 O / Li 2 O.
- I (total); Time 3.5 s calculated according to I (total) I (Na) + I (K) x 0.65 + I (Li) x 2.09
- the glasses according to the invention thus show a reduced alkali vaporization and are therefore outstandingly suitable for the production of pharmaceutical primary packaging materials, for example ampoules.
Landscapes
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Geochemistry & Mineralogy (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Glass Compositions (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01956543A EP1303461A1 (de) | 2000-07-22 | 2001-07-18 | Borosilicatglas hoher chemischer beständigkeit und dessen verwendungen |
US10/088,618 US6794323B2 (en) | 2000-07-22 | 2001-07-18 | Borosilicate glass with high chemical resistance and use thereof |
JP2002513835A JP5047443B2 (ja) | 2000-07-22 | 2001-07-18 | 耐薬品性の高いホウケイ酸ガラス、およびその使用 |
AU2001278494A AU2001278494A1 (en) | 2000-07-22 | 2001-07-18 | Borosilicate glass with high chemical resistance and use thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10035801.2 | 2000-07-22 | ||
DE10035801A DE10035801B4 (de) | 2000-07-22 | 2000-07-22 | Borosilicatglas hoher chemischer Beständigkeit und dessen Verwendungen |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002008134A1 true WO2002008134A1 (de) | 2002-01-31 |
Family
ID=7649901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/008285 WO2002008134A1 (de) | 2000-07-22 | 2001-07-18 | Borosilicatglas hoher chemischer beständigkeit und dessen verwendungen |
Country Status (8)
Country | Link |
---|---|
US (1) | US6794323B2 (de) |
EP (1) | EP1303461A1 (de) |
JP (1) | JP5047443B2 (de) |
CN (1) | CN1203018C (de) |
AU (1) | AU2001278494A1 (de) |
CZ (1) | CZ20021046A3 (de) |
DE (1) | DE10035801B4 (de) |
WO (1) | WO2002008134A1 (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2065347A1 (de) * | 2007-11-30 | 2009-06-03 | Corning Incorporated | Härtbare Frittenzusammensetzung sowie Zusammensetzungen und Geräte daraus |
EP3345876A4 (de) * | 2015-09-03 | 2019-06-19 | Nippon Electric Glass Co., Ltd. | Borosilikatglas für medizinische behälter, glasrohr für medizinische behälter und verfahren zur herstellung medizinischer behälter |
CN113582538A (zh) * | 2021-07-12 | 2021-11-02 | 甘肃旭康材料科技有限公司 | 一种硼硅玻璃组合物、硼硅玻璃及其制备方法和应用 |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1426345A1 (de) * | 2002-12-03 | 2004-06-09 | Corning Incorporated | Borsilikatglaszusammensetzungen und deren Anwendungen |
JP4795651B2 (ja) * | 2003-06-06 | 2011-10-19 | ショット アクチエンゲゼルシャフト | 特に蛍光ランプへ用いる高耐薬品性紫外線吸収ガラス、製造方法、及び使用方法 |
DE102004008559B9 (de) * | 2004-02-18 | 2007-05-03 | Schott Ag | Verwendung eines Glases für Glas-Metall-Verbindungen |
WO2006100687A1 (en) * | 2005-03-24 | 2006-09-28 | Dabur Pharma Ltd. | Disodium pamidronate aqueous formulation |
WO2007001881A2 (en) * | 2005-06-28 | 2007-01-04 | Corning Incorporated | Uv transmitting glasses |
US7358206B2 (en) * | 2006-05-12 | 2008-04-15 | Corning Incorporated | UV transmitting glasses |
US7989379B2 (en) * | 2005-06-29 | 2011-08-02 | Nippon Electric Glass Co., Ltd. | Optical glass |
DE102007048738B4 (de) * | 2007-10-05 | 2010-03-18 | Loptek Glasfasertechnik Gmbh & Co. Kg | Metallisches Schutzrohr mit temperaturfest integriertem optischen Fenster |
WO2009070237A1 (en) | 2007-11-29 | 2009-06-04 | Corning Incorporated | Glasses having improved toughness and scratch resistance |
DE102008001496A1 (de) | 2008-04-30 | 2009-11-05 | Schott Ag | Borosilikatglas mit UV-Blockung für Pharmaverpackungen |
DE102008047280A1 (de) | 2008-09-16 | 2010-04-01 | Schott Ag | Glas und Verwendung eines Glases für Glas-Metall-Verbindungen |
DE102008043317B4 (de) * | 2008-10-30 | 2013-08-08 | Schott Ag | Verwendung eines solarisationsbeständigen Glases mit einer definierten Steigung der UV-Kante für einen Strahler für Bewitterungsanlagen |
DE102009038475B4 (de) | 2009-08-21 | 2011-07-07 | Schott Ag, 55122 | Verwendung eines Glases für Glas-Metall-Verbindungen |
ES2358656B1 (es) * | 2009-10-28 | 2012-01-13 | Abengoa Solar New Technologies, S.A. | Nuevas composiciones de vidrio y procedimiento para realizar una union vidrio-metal. |
IT1397100B1 (it) | 2009-12-24 | 2012-12-28 | Gerresheimer Pisa Spa | Composizione di vetro per collettori solari termici tubolari provvisti di una giunzione vetro-metallo. |
CA2841429C (en) | 2010-08-26 | 2019-04-16 | Michael Joseph Timlin, Iii | A binary condensing thermal power cycle |
DE202010014985U1 (de) | 2010-10-30 | 2010-12-30 | Schott Ag | Bororsilicatglas hoher chemischer Beständigkeit und geringer Entglasungsneigung |
DE102011084543B4 (de) | 2011-10-14 | 2017-04-27 | Schott Ag | Borosilicatglas mit hoher hydrolytischer Beständigkeit |
US9517966B2 (en) | 2011-10-25 | 2016-12-13 | Corning Incorporated | Glass compositions with improved chemical and mechanical durability |
RU2691186C2 (ru) | 2011-10-25 | 2019-06-11 | Корнинг Инкорпорейтед | Щелочноземельные алюмосиликатные стеклянные композиции с улучшенной химической и механической стойкостью |
US10350139B2 (en) | 2011-10-25 | 2019-07-16 | Corning Incorporated | Pharmaceutical glass packaging assuring pharmaceutical sterility |
EP2771294B1 (de) | 2011-10-25 | 2017-12-13 | Corning Incorporated | Pharmazeutische delaminationsresistente glasbehälter mit pharmazeutischen wirkstoffen |
EP2683666B1 (de) | 2011-10-25 | 2017-12-13 | Corning Incorporated | Glaszusammensetzungen mit verbesserter chemischer und mechanischer beständigkeit |
KR101145729B1 (ko) * | 2011-11-11 | 2012-05-16 | 주식회사 금비 | 유리 조성물 |
CN102515522B (zh) * | 2011-12-08 | 2014-10-15 | 山东力诺新材料有限公司 | 一种硼硅玻璃、玻璃-金属匹配封接件及其制备方法和应用 |
DE102012202696B4 (de) * | 2012-02-22 | 2015-10-15 | Schott Ag | Verfahren zur Herstellung von Gläsern und Glaskeramiken, Glas und Glaskeramik und deren Verwendung |
US10273048B2 (en) | 2012-06-07 | 2019-04-30 | Corning Incorporated | Delamination resistant glass containers with heat-tolerant coatings |
JP2014088293A (ja) * | 2012-10-31 | 2014-05-15 | Nippon Electric Glass Co Ltd | 医薬用ガラス及び医薬用ガラス管 |
US9603775B2 (en) | 2013-04-24 | 2017-03-28 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9713572B2 (en) * | 2013-04-24 | 2017-07-25 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9849066B2 (en) | 2013-04-24 | 2017-12-26 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9717648B2 (en) | 2013-04-24 | 2017-08-01 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9839579B2 (en) | 2013-04-24 | 2017-12-12 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9707155B2 (en) * | 2013-04-24 | 2017-07-18 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9707154B2 (en) * | 2013-04-24 | 2017-07-18 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9700486B2 (en) | 2013-04-24 | 2017-07-11 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9707153B2 (en) | 2013-04-24 | 2017-07-18 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9700485B2 (en) | 2013-04-24 | 2017-07-11 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9717649B2 (en) * | 2013-04-24 | 2017-08-01 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
DE202013011766U1 (de) * | 2013-04-26 | 2014-09-30 | Schott Ag | Borosilikatglas mit verbesserter hydrolytischer Beständigkeit zur bevorzugten Verwendung im Pharmabereich |
JP6455799B2 (ja) | 2013-06-06 | 2019-01-23 | 日本電気硝子株式会社 | 医薬品容器用ガラス管及び医薬品容器 |
JP6508507B2 (ja) * | 2013-09-02 | 2019-05-08 | 日本電気硝子株式会社 | 医薬容器用ホウケイ酸ガラス |
US9670088B2 (en) | 2014-05-20 | 2017-06-06 | Corning Incorporated | Scratch resistant glass and method of making |
CN104176930B (zh) * | 2014-07-21 | 2018-03-09 | 沧州四星光热玻璃有限公司 | Φ40‑70mm药用中性硼硅玻璃管及其制作方法 |
CN104261676B (zh) * | 2014-09-04 | 2017-02-15 | 东莞市长安东阳光铝业研发有限公司 | 一种中性硼硅玻璃及其应用 |
JP6811941B2 (ja) * | 2015-07-17 | 2021-01-13 | 日本電気硝子株式会社 | 医薬容器用ホウケイ酸ガラス |
DE102015214431B3 (de) | 2015-07-29 | 2016-12-22 | Schott Ag | Bor-armes Zirkonium-freies Neutralglas mit optimiertem Alkaliverhältnis |
JP6653073B2 (ja) * | 2015-09-03 | 2020-02-26 | 日本電気硝子株式会社 | 医薬容器用ホウケイ酸ガラス |
CN105271756B (zh) * | 2015-09-30 | 2018-01-19 | 深圳凯世光研股份有限公司 | 一种过渡封接玻璃 |
DE102017102900A1 (de) * | 2016-05-04 | 2017-11-09 | Schott Ag | Pharmapackmittel mit einem chemisch beständigen Glas |
DE102016226030B4 (de) | 2016-12-22 | 2018-07-05 | Schott Ag | Bariumfreies Borosilicatglas |
WO2018121491A1 (zh) | 2016-12-29 | 2018-07-05 | 广东东阳光药业有限公司 | 高耐化学性的硼硅酸盐玻璃及其应用 |
CN114292022A (zh) | 2017-10-24 | 2022-04-08 | 广东东阳光药业有限公司 | 抗紫外线耐碱硼硅酸盐玻璃及其应用 |
CN109721246B (zh) * | 2017-10-30 | 2021-12-07 | 浙江晶华玻璃有限公司 | 一种可耐1300摄氏度高温火抛不变形的玻璃瓶及其制备方法 |
CN110117156B (zh) * | 2018-02-05 | 2021-07-16 | 绥中明晖工业技术有限公司 | 一种高硼硅防爆玻璃罩制备方法 |
DE102018104163A1 (de) * | 2018-02-23 | 2019-08-29 | Schott Ag | Glasfläschchen mit geringer Migrationslast |
DE102018104164A1 (de) | 2018-02-23 | 2019-08-29 | Schott Ag | Glasfläschchen mit erhöhter chemischer Beständigkeit |
EP3584228B1 (de) * | 2018-06-18 | 2023-08-09 | Schott Ag | Borosilikatglasartikel mit niedrigem borgehalt |
WO2020036760A1 (en) * | 2018-08-13 | 2020-02-20 | Corning Incorporated | Ion exchangeable borosilicate glass compositions and glass articles formed from the same |
CN110563332A (zh) * | 2019-10-14 | 2019-12-13 | 江西春山新能源有限公司 | 一种高性能高硼硅玻璃材料的制备方法 |
CN111018351B (zh) * | 2019-12-06 | 2022-03-01 | 西安赛尔电子材料科技有限公司 | 热电池用钛与可伐合金封接玻璃材料及制备方法和应用 |
CN111977972B (zh) * | 2020-09-01 | 2022-11-08 | 湖南旗滨医药材料科技有限公司 | 硼硅酸盐玻璃及其制备方法 |
US11951713B2 (en) | 2020-12-10 | 2024-04-09 | Corning Incorporated | Glass with unique fracture behavior for vehicle windshield |
CN113831013A (zh) * | 2021-08-31 | 2021-12-24 | 甘肃旭康材料科技有限公司 | 中性硼硅玻璃组合物、中性硼硅玻璃及其制备方法与应用 |
CN113860729B (zh) * | 2021-10-25 | 2023-01-10 | 北京工业大学 | 一种中硼硅药用玻璃 |
CN115159842B (zh) * | 2022-06-30 | 2023-11-21 | 凯盛君恒(蚌埠)有限公司 | 一种抗碱性强低析晶低节瘤的拉管用中硼硅玻璃 |
CN116920978B (zh) * | 2023-07-10 | 2024-03-22 | 广东顺德中科优联医学检验有限公司 | 检测血清中儿茶酚胺用避光抗氧化试管及其制备方法 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3310846A1 (de) | 1983-03-25 | 1984-09-27 | Owens-Illinois, Inc., Toledo, Ohio | Barium-fries laboratoriumsglas der type i klasse b |
DE3722130A1 (de) | 1987-07-02 | 1989-01-12 | Schott Glaswerke | Borosilikatglas |
JPH03218940A (ja) * | 1990-01-23 | 1991-09-26 | Toshiba Glass Co Ltd | 紫外線透過ガラス |
JPH0474731A (ja) * | 1990-07-06 | 1992-03-10 | Nippon Electric Glass Co Ltd | 医薬用硼珪酸ガラス |
DE4230607C1 (de) | 1992-09-12 | 1994-01-05 | Schott Glaswerke | Chemisch und thermisch hochbelastbares, mit Wolfram verschmelzbares Borosilikatglas und dessen Verwendung |
DE4430710C1 (de) | 1994-08-30 | 1996-05-02 | Jenaer Glaswerk Gmbh | Borsäurearmes Borosilikatglas und seine Verwendung |
DE19536708C1 (de) | 1995-09-30 | 1996-10-31 | Jenaer Glaswerk Gmbh | Zirkon- und lithiumoxidhaltiges Borosilicatglas hoher chemischer Beständigkeit und geringer Viskosität und dessen Verwendung |
JPH08333136A (ja) * | 1995-06-05 | 1996-12-17 | Nippon Electric Glass Co Ltd | コバール封着用ガラス |
DE29702816U1 (de) * | 1997-02-18 | 1997-04-10 | Schott Glaswerke, 55122 Mainz | Sterilisierbarer Glasbehälter für medizinische Zwecke, insbesondere zur Aufbewahrung pharmazeutischer oder diagnostischer Produkte |
DE19842942A1 (de) | 1998-09-18 | 2000-04-13 | Schott Glas | Borosilicatglas hoher chemischer Beständigkeit und dessen Verwendung |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2413552B2 (de) * | 1974-03-21 | 1976-09-02 | Jenaer Glaswerk Schott & Gen., 6500 Mainz | Brandsichere glasscheiben |
US3985535A (en) * | 1975-06-19 | 1976-10-12 | Smithkline Corporation | Method of making glass ampul for jet injector |
DE2756555C3 (de) * | 1977-12-19 | 1982-12-02 | Schott Glaswerke, 6500 Mainz | Thermisch vorspannbare Gläser mit hoher Temperaturwechselfestigkeit und Wärmedehnungskoeffizienten im Temperaturbereich von 20 bis 300°C von 33,9 bis 53,2 mal 10↑-↑↑7↑/°C auf der Basis SiO↓2↓-B↓2↓O↓3↓-Al↓2↓O↓3↓-Na↓2↓O |
US4386164A (en) * | 1981-12-14 | 1983-05-31 | Owens-Illinois, Inc. | Barium-free Type I, Class B laboratory soda-alumina-borosilicate glass |
FR2558152B1 (fr) * | 1984-01-13 | 1992-03-27 | Corning Glass Works | Verres a usage ophtalmique de faible densite, absorbant les radiations ultraviolettes et ayant une haute transmission dans le visible et lentilles correctrices constituees de ces verres |
DD301821A7 (de) * | 1990-03-23 | 1994-04-07 | Jenaer Glaswerk Gmbh | Zirkonhaltiges borosilikatglas |
JPH08267278A (ja) * | 1995-03-30 | 1996-10-15 | Kobe Steel Ltd | 溶接材料用アルカリガラス |
DE19622550A1 (de) * | 1996-06-05 | 1997-12-11 | Schott Glaswerke | Glasbehälter insbesondere zur Aufbewahrung pharmazeutischer oder diagnostischer Lösungen |
DE19801861C2 (de) * | 1998-01-20 | 2001-10-18 | Schott Glas | Verfahren zum Herstellen eines hohlen, innenbeschichteten Glasformkörpers |
-
2000
- 2000-07-22 DE DE10035801A patent/DE10035801B4/de not_active Expired - Fee Related
-
2001
- 2001-07-18 JP JP2002513835A patent/JP5047443B2/ja not_active Expired - Fee Related
- 2001-07-18 US US10/088,618 patent/US6794323B2/en not_active Expired - Lifetime
- 2001-07-18 AU AU2001278494A patent/AU2001278494A1/en not_active Abandoned
- 2001-07-18 CN CNB018028411A patent/CN1203018C/zh not_active Expired - Lifetime
- 2001-07-18 CZ CZ20021046A patent/CZ20021046A3/cs unknown
- 2001-07-18 WO PCT/EP2001/008285 patent/WO2002008134A1/de active Application Filing
- 2001-07-18 EP EP01956543A patent/EP1303461A1/de not_active Withdrawn
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3310846A1 (de) | 1983-03-25 | 1984-09-27 | Owens-Illinois, Inc., Toledo, Ohio | Barium-fries laboratoriumsglas der type i klasse b |
DE3722130A1 (de) | 1987-07-02 | 1989-01-12 | Schott Glaswerke | Borosilikatglas |
JPH03218940A (ja) * | 1990-01-23 | 1991-09-26 | Toshiba Glass Co Ltd | 紫外線透過ガラス |
JPH0474731A (ja) * | 1990-07-06 | 1992-03-10 | Nippon Electric Glass Co Ltd | 医薬用硼珪酸ガラス |
DE4230607C1 (de) | 1992-09-12 | 1994-01-05 | Schott Glaswerke | Chemisch und thermisch hochbelastbares, mit Wolfram verschmelzbares Borosilikatglas und dessen Verwendung |
DE4430710C1 (de) | 1994-08-30 | 1996-05-02 | Jenaer Glaswerk Gmbh | Borsäurearmes Borosilikatglas und seine Verwendung |
JPH08333136A (ja) * | 1995-06-05 | 1996-12-17 | Nippon Electric Glass Co Ltd | コバール封着用ガラス |
DE19536708C1 (de) | 1995-09-30 | 1996-10-31 | Jenaer Glaswerk Gmbh | Zirkon- und lithiumoxidhaltiges Borosilicatglas hoher chemischer Beständigkeit und geringer Viskosität und dessen Verwendung |
DE29702816U1 (de) * | 1997-02-18 | 1997-04-10 | Schott Glaswerke, 55122 Mainz | Sterilisierbarer Glasbehälter für medizinische Zwecke, insbesondere zur Aufbewahrung pharmazeutischer oder diagnostischer Produkte |
DE19842942A1 (de) | 1998-09-18 | 2000-04-13 | Schott Glas | Borosilicatglas hoher chemischer Beständigkeit und dessen Verwendung |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2065347A1 (de) * | 2007-11-30 | 2009-06-03 | Corning Incorporated | Härtbare Frittenzusammensetzung sowie Zusammensetzungen und Geräte daraus |
WO2009070290A1 (en) * | 2007-11-30 | 2009-06-04 | Corning Incorporated | Durable frit composition & composites and devices comprised thereof |
US8162005B2 (en) | 2007-11-30 | 2012-04-24 | Corning Incorporated | Durable frit composition and composites and devices comprised thereof |
EP3345876A4 (de) * | 2015-09-03 | 2019-06-19 | Nippon Electric Glass Co., Ltd. | Borosilikatglas für medizinische behälter, glasrohr für medizinische behälter und verfahren zur herstellung medizinischer behälter |
CN113582538A (zh) * | 2021-07-12 | 2021-11-02 | 甘肃旭康材料科技有限公司 | 一种硼硅玻璃组合物、硼硅玻璃及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CZ20021046A3 (cs) | 2003-11-12 |
CN1203018C (zh) | 2005-05-25 |
JP2004504258A (ja) | 2004-02-12 |
JP5047443B2 (ja) | 2012-10-10 |
AU2001278494A1 (en) | 2002-02-05 |
EP1303461A1 (de) | 2003-04-23 |
US20030087745A1 (en) | 2003-05-08 |
DE10035801A1 (de) | 2002-02-14 |
US6794323B2 (en) | 2004-09-21 |
CN1392868A (zh) | 2003-01-22 |
DE10035801B4 (de) | 2008-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE10035801B4 (de) | Borosilicatglas hoher chemischer Beständigkeit und dessen Verwendungen | |
EP0992462B1 (de) | Borosilicatglas hoher chemischer Beständigkeit und dessen Verwendung | |
DE19616633C1 (de) | Chemisch vorspannbare Aluminosilicatgläser und deren Verwendung | |
DE10337362B4 (de) | Borosilicatglas und seine Verwendungen | |
DE69428651T2 (de) | Eine Lichtwellenlängen wandelnde Glaskeramik und Verfahren zu ihrer Herstellung | |
EP0699636B1 (de) | Borsäurearmes Borosilikatglas und seine Verwendung | |
DE69308701T2 (de) | Transparente kristallisierte Glaskeramik mit geringem Ausdehnungskoeffizienten | |
DE69017791T2 (de) | Flachglaszusammensetzung mit verbesserten Schmelz- und Härteeigenschaften. | |
DE2905875C2 (de) | Optisches Glas im System P↓2↓O↓5↓-Nb↓2↓O↓5↓ | |
DE4013392C2 (de) | ||
WO2003097544A1 (de) | Borosilicatglas mit uv-blockung und seine verwendung sowie fluoreszenzlampe | |
EP2649019A2 (de) | Borfreies universalglas | |
DE3826586A1 (de) | Uv-durchlaessige glaeser | |
DE69509736T2 (de) | Farblose ophthalmische Gläser | |
EP0913366B1 (de) | Erdalkalialuminoborosilicatglas für Lampenkolben und dessen Verwendung | |
DE60300906T2 (de) | Optisches Glas mit anomaler Dispersion | |
DE10238915B3 (de) | Borosilicatglas mit hoher hydrolytischer Beständigkeit und Verwendungen | |
DE10025465C2 (de) | Lithiumoxidarmes Borosilicatglas und seine Verwendung | |
DE112020000495T5 (de) | Glas für arzneimittelbehälter und glasrohr für arzneimittelbehälter undarzneimittelbehälter unter verwendung desselben | |
DE112019006477T5 (de) | Glas für Arzneimittelbehälter und Arzneimittelbehälter-Glasrohr und Arzneimittelbehälter, die selbiges verwenden | |
DE4309701C1 (de) | Bleifreies Kristallglas mit hoher Lichttransmission | |
DE3037004A1 (de) | Bei niedrigen temperaturen formbare glaeser | |
DE2109655C3 (de) | Alkalifreies farbloses optisches Glas mit anomaler Teildispersion im kurzwelligen Bereich und großer | |
DE10027699B4 (de) | Borosilicatglas hoher chemischer Beständigkeit und dessen Verwendung | |
DE4303474C2 (de) | Blei- und bariumfreies Kristallglas mit hoher Lichttransmission |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2002 513835 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2002-1046 Country of ref document: CZ Ref document number: IN/PCT/2002/444/CHE Country of ref document: IN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2002 2002110449 Country of ref document: RU Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001956543 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018028411 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10088618 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001956543 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV2002-1046 Country of ref document: CZ |